John K. Scott Jr. - Jun 29, 2023 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)

Role
Director, 10%+ Owner
Signature
/s/ Joseph W. Meyer for John K. Scott, Jr. by power of attorney
Stock symbol
NAVB
Transactions as of
Jun 29, 2023
Transactions value $
$1,073,600
Form type
4
Date filed
6/30/2023, 10:46 AM
Previous filing
Jun 15, 2023
Next filing
Dec 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAVB Common Stock Award $1.07M +12.2M +62.39% $0.09 31.8M Jun 29, 2023 Direct F1
holding NAVB Common Stock 10.1K Jun 29, 2023 By spouse and children F2
holding NAVB Series G Redeemable Preferred Stock 2.27K Jun 29, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Navidea entered into a Letter Agreement with the Reporting Person, pursuant to which the Company agreed to repay $1,073,600 principal amount of an outstanding Term Note by issuing to the Reporting Person 12,200,000 shares of Common Stock, based on the closing stock price of $0.088 per share on June 28, 2023.
F2 Includes 2,639 shares of Common Stock owned by the Reporting Person's spouse and 7,500 shares of Common Stock owned by the Reporting Person's children. The Reporting Person may be deemed tohave shared voting and/or dispositive power with respect to such shares.